CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy
{{output}}
The remarkable advances in interferon-sparing, all-oral hepatitis C virus (HCV) treatment were a highlight of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI). The backbone of the nucleotide inhibitor sofosbuvir and the nonstructural pro... ...
